中国人群肺癌风险位点鉴定及多基因风险评分:大规模前瞻性队列研究
该研究通过新基因分型19 546例中国非小细胞肺癌病例对照样本,并对27 120例病例和27 355例对照的全基因组关联研究进行荟萃分析,鉴定出19个与非小细胞肺癌风险显著相关的易感位点(含6个新位点)。
要点
- 鉴定出19个与非小细胞肺癌风险显著相关的易感位点,其中6个为新位点。
- 多基因风险评分可独立于年龄和吸烟包年进行风险分层。
核心结论
- 全基因组关联研究衍生的多基因风险评分可有效区分中国人群肺癌高风险亚群。
研究设计与样本
- 新基因分型19 546例中国非小细胞肺癌病例和对照样本。
- 对27 120例非小细胞肺癌患者和27 355例无该病个体进行全基因组关联研究荟萃分析(含13 327例中国裔病例和13 328例中国裔对照,以及13 793例欧洲裔病例和14 027例欧洲裔对照)。
- 在中国慢性病前瞻性队列95 408人中评估多基因风险评分的预测效用,随访超过10年。
主要发现
- 多基因风险评分在中国慢性病前瞻性队列中以剂量反应方式预测肺癌发病。
- 低、中、高遗传风险个体的肺癌事件曲线持续分离。
- 多基因风险评分是独立于年龄和吸烟包年的有效风险分层指标。
临床怎么用
- 可利用多基因风险评分识别中国人群中的肺癌高风险亚群。
- 多基因风险评分可作为独立于年龄和吸烟包年的风险分层工具。
- 基于多基因风险评分的肺癌筛查方案可能有助于中国人群的精准预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic variation has an important role in the development of non-small-cell lung cancer (NSCLC). However, genetic factors for lung cancer have not been fully identified, especially in Chinese populations, which limits the use of existing polygenic risk scores (PRS) to identify subpopulations at high risk of lung cancer for prevention. We therefore aimed to identify novel loci associated with NSCLC risk, and generate a PRS and evaluate its utility and effectiveness in the prediction of lung cancer risk in Chinese populations. METHODS: To systematically identify genetic variants for NSCLC risk, we newly genotyped 19 546 samples from Chinese NSCLC cases and controls from the Nanjing Medical University Global Screening Array Project and did a meta-analysis of genome-wide association studies (GWASs) of 27 120 individuals with NSCLC and 27 355 without NSCLC (13 327 cases and 13 328 controls of Chinese descent as well as 13 793 cases and 14 027 controls of European descent). We then built a PRS for Chinese populations from all reported single-nucleotide polymorphisms that have been reported to be associated with lung cancer risk at genome-wide significance level. We evaluated the utility and effectiveness of the generated PRS in predicting subpopulations at high-risk of lung cancer in an independent prospective cohort of 95 408 individuals from the China Kadoorie Biobank (CKB) with more than 10 years' follow-up. FINDINGS: We identified 19 susceptibility loci to be significantly associated with NSCLC risk at p≤5·0 × 10-8, including six novel loci. When applied to the CKB cohort, the PRS of the risk loci successfully predicted lung cancer incident cases in a dose-response manner in participants at a high genetic risk (top 10%) than those at a low genetic risk (bottom 10%; adjusted hazard ratio 1·96, 95% CI 1·53-2·51; ptrend=2·02 × 10-9). Specially, we observed consistently separated curves of lung cancer events in individuals at low, intermediate, and high genetic risk, respectively, and PRS was an independent effective risk stratification indicator beyond age and smoking pack-years. INTERPRETATION: We have shown for the first time that GWAS-derived PRS can be effectively used in discriminating subpopulations at high risk of lung cancer, who might benefit from a practically feasible PRS-based lung cancer screening programme for precision prevention in Chinese populations. FUNDING: National Natural Science Foundation of China, the Priority Academic Program for the Development of Jiangsu Higher Education Institutions, National Key R&D Program of China, Science Foundation for Distinguished Young Scholars of Jiangsu, and China's Thousand Talents Program.
引用
- Dai J, Lv J, Zhu M, et al. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019. PMID: 31326317. doi:10.1016/S2213-2600(19)30144-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。